New Oncolytic Virus Shows Improved Effectiveness in Preclinical Testing

A new fourth-generation oncolytic virus designed to both kill cancer cells and inhibit blood-vessel growth has shown greater effectiveness than earlier versions when tested in animal models of human brain cancer.

More...